Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 7 | 2022 | 643 | 0.950 |
Why?
|
| Endothelial Cells | 1 | 2022 | 308 | 0.650 |
Why?
|
| MicroRNAs | 1 | 2022 | 426 | 0.560 |
Why?
|
| Obesity | 5 | 2014 | 1067 | 0.450 |
Why?
|
| Metabolic Diseases | 2 | 2023 | 33 | 0.410 |
Why?
|
| Osteoporosis | 2 | 2009 | 34 | 0.390 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 105 | 0.340 |
Why?
|
| Medical Staff, Hospital | 1 | 2009 | 13 | 0.340 |
Why?
|
| Clinical Protocols | 1 | 2009 | 36 | 0.330 |
Why?
|
| Insulin Resistance | 1 | 2011 | 184 | 0.330 |
Why?
|
| Fractures, Bone | 1 | 2009 | 53 | 0.320 |
Why?
|
| Medicare | 3 | 2017 | 195 | 0.250 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2004 | 1 | 0.240 |
Why?
|
| Human Growth Hormone | 1 | 2004 | 20 | 0.240 |
Why?
|
| Growth Disorders | 1 | 2004 | 22 | 0.240 |
Why?
|
| Fatty Liver | 1 | 2023 | 64 | 0.220 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 183 | 0.200 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 190 | 0.190 |
Why?
|
| Humans | 22 | 2023 | 37093 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 626 | 0.190 |
Why?
|
| Exosomes | 1 | 2022 | 101 | 0.180 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2020 | 43 | 0.180 |
Why?
|
| Vitamin D | 2 | 2014 | 196 | 0.180 |
Why?
|
| Overweight | 2 | 2014 | 247 | 0.170 |
Why?
|
| Insulin | 5 | 2016 | 236 | 0.170 |
Why?
|
| Pilot Projects | 4 | 2023 | 661 | 0.170 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 179 | 0.160 |
Why?
|
| Male | 15 | 2018 | 20025 | 0.150 |
Why?
|
| Female | 15 | 2018 | 20969 | 0.140 |
Why?
|
| Pharmacies | 1 | 2017 | 21 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 40 | 0.140 |
Why?
|
| Community Pharmacy Services | 1 | 2017 | 24 | 0.140 |
Why?
|
| Body Mass Index | 4 | 2014 | 854 | 0.140 |
Why?
|
| Competitive Bidding | 1 | 2016 | 1 | 0.140 |
Why?
|
| Adult | 9 | 2018 | 11712 | 0.130 |
Why?
|
| Glucose Tolerance Test | 2 | 2013 | 68 | 0.130 |
Why?
|
| Health Services Needs and Demand | 2 | 2013 | 146 | 0.120 |
Why?
|
| Complementary Therapies | 1 | 2015 | 46 | 0.120 |
Why?
|
| Retrospective Studies | 5 | 2016 | 2026 | 0.120 |
Why?
|
| Child | 4 | 2013 | 3131 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2015 | 138 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2015 | 217 | 0.110 |
Why?
|
| Leptin | 2 | 2013 | 118 | 0.110 |
Why?
|
| Adolescent | 5 | 2015 | 5363 | 0.110 |
Why?
|
| Vitamins | 1 | 2014 | 94 | 0.110 |
Why?
|
| Ghrelin | 1 | 2013 | 13 | 0.110 |
Why?
|
| Colonic Polyps | 1 | 2014 | 67 | 0.110 |
Why?
|
| Middle Aged | 8 | 2018 | 10129 | 0.110 |
Why?
|
| United States | 6 | 2022 | 4223 | 0.100 |
Why?
|
| C-Peptide | 1 | 2011 | 7 | 0.100 |
Why?
|
| Aged | 6 | 2018 | 6741 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1130 | 0.100 |
Why?
|
| Ideal Body Weight | 1 | 2011 | 3 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 2379 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 905 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 404 | 0.090 |
Why?
|
| Adiponectin | 1 | 2011 | 55 | 0.090 |
Why?
|
| District of Columbia | 3 | 2022 | 71 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2011 | 63 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2011 | 116 | 0.090 |
Why?
|
| Pakistan | 2 | 2020 | 20 | 0.090 |
Why?
|
| Causality | 1 | 2009 | 44 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 75 | 0.080 |
Why?
|
| Awareness | 1 | 2009 | 65 | 0.080 |
Why?
|
| Urban Population | 1 | 2011 | 333 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 441 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 485 | 0.080 |
Why?
|
| Telemedicine | 1 | 2011 | 182 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 208 | 0.070 |
Why?
|
| Young Adult | 3 | 2013 | 4268 | 0.070 |
Why?
|
| Comorbidity | 1 | 2009 | 623 | 0.070 |
Why?
|
| Minority Groups | 1 | 2011 | 596 | 0.070 |
Why?
|
| Mass Screening | 1 | 2009 | 462 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 59 | 0.060 |
Why?
|
| Growth | 1 | 2004 | 12 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2004 | 78 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2004 | 68 | 0.060 |
Why?
|
| Body Height | 1 | 2004 | 53 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 191 | 0.060 |
Why?
|
| Sex Factors | 2 | 2018 | 898 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 17 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 2721 | 0.050 |
Why?
|
| Physicians | 1 | 2004 | 163 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 129 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 190 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 223 | 0.050 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2020 | 14 | 0.050 |
Why?
|
| Halogenation | 1 | 2020 | 19 | 0.050 |
Why?
|
| ras Proteins | 1 | 2020 | 51 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 360 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 1996 | 3 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 2017 | 54 | 0.040 |
Why?
|
| Thyroxine | 1 | 1996 | 19 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 1996 | 18 | 0.040 |
Why?
|
| Pharmacists | 1 | 2017 | 53 | 0.040 |
Why?
|
| Logistic Models | 2 | 2013 | 923 | 0.030 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2016 | 29 | 0.030 |
Why?
|
| Rural Population | 1 | 2018 | 294 | 0.030 |
Why?
|
| Medicaid | 1 | 2017 | 109 | 0.030 |
Why?
|
| Perception | 1 | 2017 | 195 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 1369 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 348 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 1067 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 143 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1455 | 0.030 |
Why?
|
| Medical Audit | 1 | 2013 | 25 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 62 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 138 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2014 | 104 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 2013 | 65 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 885 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 1378 | 0.030 |
Why?
|
| Fasting | 1 | 2013 | 54 | 0.030 |
Why?
|
| Hospitalization | 1 | 2016 | 388 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2011 | 34 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2014 | 208 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 30 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 97 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2011 | 12 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 233 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2011 | 353 | 0.020 |
Why?
|
| Self Care | 1 | 2011 | 159 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 689 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1742 | 0.020 |
Why?
|
| Health Literacy | 1 | 2011 | 105 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2011 | 446 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 560 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3562 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2004 | 10 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 864 | 0.010 |
Why?
|
| Tea | 1 | 2004 | 45 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 15081 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 321 | 0.010 |
Why?
|
| Calcium, Dietary | 1 | 2004 | 85 | 0.010 |
Why?
|
| HIV Infections | 1 | 1996 | 2303 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2004 | 1492 | 0.010 |
Why?
|
| Exercise | 1 | 2004 | 613 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1996 | 14 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1996 | 17 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 974 | 0.010 |
Why?
|
| Infant | 1 | 1996 | 1046 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 1418 | 0.010 |
Why?
|